AVR 3.71% $13.48 anteris technologies ltd

Interview with CEO Wayne Paterson re: 2020 milestones, page-26

  1. 512 Posts.
    lightbulb Created with Sketch. 64
    yes optimal time will be if/when this valve gets an FDA approval. that will take several years and more cash upto $50mill guestimate. Feel they are now heading in the right direction. This current strategy should have being done at least 4years ago. My major concern is way management always dealing with issues also they are all mainly expharma, feel they made some expensive wrong mistakes and frequent ongoing changes which is big red flag, no stability. Biggest booster for me if we get some med tech expertise to finally lead company someone who is being through and experience this and not someone with backgroud in large global pharma drug business Feel this would be much better however the person at helm wants to continue and with limited financial stake in comapny that is my biggest ongoign with my now demished investment.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$13.48
Change
-0.520(3.71%)
Mkt cap ! $294.2M
Open High Low Value Volume
$14.20 $14.41 $13.30 $107.4K 7.859K

Buyers (Bids)

No. Vol. Price($)
3 17 $13.27
 

Sellers (Offers)

Price($) Vol. No.
$13.47 326 2
View Market Depth
Last trade - 14.31pm 28/08/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.